← Browse by Condition
Medical Condition

alveolar soft part sarcoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT03016819 Phase 3
Recruiting

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

Enrollment
325 pts
Location
United States, China...
Sponsor
Advenchen Laboratories, LLC
View Trial →